PackGene Biotech Inc., an adeno-associated virus (AAV) vector contract research organization (CRO) and contract development and manufacturing organization (CDMO), announced the expansion of its U.S. services with a new cGMP biomanufacturing and processing facility in Houston.
The company broke ground on the full-service operations center this week to support a growing base of U.S. customers advancing gene therapy programs.
